| Excitotoxicity: bridge to various triggers in neurodegenerative disorders A Mehta, M Prabhakar, P Kumar, R Deshmukh, PL Sharma European journal of pharmacology 698 (1-3), 6-18, 2013 | 747 | 2013 |
| Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease D Kaur, V Sharma, R Deshmukh Inflammopharmacology 27, 663-677, 2019 | 326 | 2019 |
| Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine—a PDE1 inhibitor R Deshmukh, V Sharma, S Mehan, N Sharma, KL Bedi European journal of pharmacology 620 (1-3), 49-56, 2009 | 241 | 2009 |
| Resistance to checkpoint inhibition in cancer immunotherapy L Barrueto, F Caminero, L Cash, C Makris, P Lamichhane, RR Deshmukh Translational oncology 13 (3), 100738, 2020 | 217 | 2020 |
| Recent advances in the neurobiology and neuropharmacology of Alzheimer’s disease K Kumar, A Kumar, RM Keegan, R Deshmukh Biomedicine & pharmacotherapy 98, 297-307, 2018 | 164 | 2018 |
| Neuroinflammation-A major cause for striatal dopaminergic degeneration in Parkinson's disease K Kaur, JS Gill, PK Bansal, R Deshmukh Journal of the neurological sciences 381, 308-314, 2017 | 97 | 2017 |
| Pentacyclic triterpenes: New tools to fight metabolic syndrome H Sharma, P Kumar, RR Deshmukh, A Bishayee, S Kumar Phytomedicine 50, 166-177, 2018 | 93 | 2018 |
| Immunotherapies and combination strategies for immuno-oncology C Barbari, T Fontaine, P Parajuli, N Lamichhane, S Jakubski, ... International journal of molecular sciences 21 (14), 5009, 2020 | 87 | 2020 |
| Annals of Diagnostic S Kumar, C Batra, SP Kataria, B Arora, G Singh, K NayanRattan, S Ratan Annals of Diagnostic Paediatric Pathology 11 (1-2), 21-23, 2007 | 84 | 2007 |
| Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats S Sharma, P Kumar, R Deshmukh Neurochemistry International 116, 104-111, 2018 | 71 | 2018 |
| Alzheimer's disease: Is this a brain specific diabetic condition? V Rani, R Deshmukh, P Jaswal, P Kumar, J Bariwal Physiology & behavior 164, 259-267, 2016 | 66 | 2016 |
| Tetrabenazine: spotlight on drug review N Kaur, P Kumar, S Jamwal, R Deshmukh, V Gauttam Annals of neurosciences 23 (3), 176-185, 2016 | 66 | 2016 |
| Animal models of hepatotoxicity GS Bhakuni, O Bedi, J Bariwal, R Deshmukh, P Kumar Inflammation Research 65, 13-24, 2016 | 65 | 2016 |
| Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies S Sharma, S Singh, V Sharma, VP Singh, R Deshmukh Biomedicine & Pharmacotherapy 70, 283-293, 2015 | 62 | 2015 |
| Effect of GLT-1 modulator and P2X7 antagonists alone and in combination in the kindling model of epilepsy in rats N Soni, P Koushal, BVK Reddy, R Deshmukh, P Kumar Epilepsy & Behavior 48, 4-14, 2015 | 53 | 2015 |
| Phosphodiesterases: regulators of cyclic nucleotide signals and novel molecular target for movement disorders S Sharma, K Kumar, R Deshmukh, PL Sharma European journal of pharmacology 714 (1-3), 486-497, 2013 | 50 | 2013 |
| Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats S Sharma, R Deshmukh Neuroscience 286, 393-403, 2015 | 49 | 2015 |
| Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation S Datta, S Jamwal, R Deshmukh, P Kumar European Journal of Pharmacology 771, 229-235, 2016 | 47 | 2016 |
| Attenuating effect of standardized lyophilized Cinnamomum zeylanicum bark extract against streptozotocin-induced experimental dementia of Alzheimer’s type J Malik, K Munjal, R Deshmukh Journal of basic and clinical physiology and pharmacology 26 (3), 275-285, 2015 | 46 | 2015 |
| The war against tuberculosis: A review of natural compounds and their derivatives M Maiolini, S Gause, J Taylor, T Steakin, G Shipp, P Lamichhane, ... Molecules 25 (13), 3011, 2020 | 41 | 2020 |
Jitender BariwalScientist IIIVerified email at thermofisher.com
